1.Application of warfarin in treating atrial fibrillation
Yaozhi LIAN ; Yun ZHANG ; Min YANG
Chinese Journal of Practical Internal Medicine 2001;0(05):-
0.05).The annual incidence of haemorrahagia was 0.49% in the low intensity group compared with 3.74% in the standard intensity group,and there was significant difference (P
2.Impact of stenting at the origin of vertebral artery on cognitive function in patients with first-onset temporal or thalamic infarction
Yaozhi HU ; Shanshan CUI ; Ligong ZHANG ; Linzhi GAO
Journal of Clinical Medicine in Practice 2024;28(13):67-71
Objective To investigate the impact of stenting at the origin of vertebral artery(VAO)on cognitive function in patients with first-onset temporal or thalamic infarction.Methods A total of 65 patients with first-onset temporal or thalamic infarction were selected as research subjects,and were diagnosed with new-onset infarction in the medial temporal lobe or thalamus by craniocere-bral magnetic resonance imaging(MRI),and severe stenosis of VAO as the responsible vessel for in-farction was confirmed by head and neck computed tomography angiography(CTA).A total of 35 pa-tients who received VAO stenting were included in the stenting group,and 30 patients who received drug-based conservative treatment were included in the control group.The Montreal Cognitive Assess-ment Scale(MoCA),Wechsler Adult Intelligence Scale-Digit Span Test(WAIS-DS),and Fuld Ob-ject Memory Evaluation Scale(FOM)scores were compared between the two groups before treatment,14 days and 3 months after treatment.Results Before treatment,there was no significant difference in the scores of each scale between the two groups(P>0.05).At 14 days and 3 months after treat-ment,the total MoCA score and the scores of visual space and executive function,delayed recall,and language dimension in the stenting group were higher than those in the control group(P<0.05).The FOM score in the stenting group was higher than that in the control group at 3 months after treat-ment(P<0.05).Conclusion Stenting can significantly improve the cognitive function of patients with temporal lobe and thalamic infarction.
3.Impact of stenting at the origin of vertebral artery on cognitive function in patients with first-onset temporal or thalamic infarction
Yaozhi HU ; Shanshan CUI ; Ligong ZHANG ; Linzhi GAO
Journal of Clinical Medicine in Practice 2024;28(13):67-71
Objective To investigate the impact of stenting at the origin of vertebral artery(VAO)on cognitive function in patients with first-onset temporal or thalamic infarction.Methods A total of 65 patients with first-onset temporal or thalamic infarction were selected as research subjects,and were diagnosed with new-onset infarction in the medial temporal lobe or thalamus by craniocere-bral magnetic resonance imaging(MRI),and severe stenosis of VAO as the responsible vessel for in-farction was confirmed by head and neck computed tomography angiography(CTA).A total of 35 pa-tients who received VAO stenting were included in the stenting group,and 30 patients who received drug-based conservative treatment were included in the control group.The Montreal Cognitive Assess-ment Scale(MoCA),Wechsler Adult Intelligence Scale-Digit Span Test(WAIS-DS),and Fuld Ob-ject Memory Evaluation Scale(FOM)scores were compared between the two groups before treatment,14 days and 3 months after treatment.Results Before treatment,there was no significant difference in the scores of each scale between the two groups(P>0.05).At 14 days and 3 months after treat-ment,the total MoCA score and the scores of visual space and executive function,delayed recall,and language dimension in the stenting group were higher than those in the control group(P<0.05).The FOM score in the stenting group was higher than that in the control group at 3 months after treat-ment(P<0.05).Conclusion Stenting can significantly improve the cognitive function of patients with temporal lobe and thalamic infarction.
4.Establishment and verification of postoperative 1-year mortality risk prediction model in elderly patients undergoing hip fracture surgery
Yaozhi CHEN ; Yingfeng ZHOU ; Lingfei PU ; Xutong ZHANG ; Kaiming YUAN ; Jun LI
Chinese Journal of Anesthesiology 2021;41(8):933-938
Objective:To establish a prediction model of postoperative 1-year mortality risk in elderly patients undergoing hip fracture surgery and verify its efficacy.Methods:Patients of both sexes, aged ≥65 yr, of American Society of Anesthesiologists physical status Ⅰ-Ⅳ, who underwent an operation for traumatic hip fracture in the Second Affiliated Hospital of Wenzhou Medical University from January 2017 to December 2018, were enrolled and randomly assigned to model group and verification group in a ratio of 3∶1.The demographic characteristics, clinical data and results such as laboratory examinations were collected.In model group, the logistic regression analysis was used to recognize the independent risk factors for 1-year mortality after procedure, and the prediction model was established.In verification group, the prediction efficacy was analyzed using the receiver operating characteristic curve, and the degree of fitting was evaluated by Hosmer-Lemeshow goodness-of-fit test.Results:Multivariate logistic analysis indicated that age ≥84 yr, Charlson comorbidity index ≥2 points, Braden score on admission to hospital ≤16 points, preoperative urea nitrogen ≥8.8 mmol/L and postoperative albumin ≤ 29.6 g/L were the independent risk factors for 1-year mortality after hip fracture surgery in elderly patients ( P<0.05). The prediction model was established based on the risk factors mentioned above.The area under receiver operating characteristic curve was 0.870, and the sensitivity and specificity were 82.8% and 80.0%, respectively.The prediction model showed good fitting ( χ2=4.672, P=0.700). Conclusion:Age ≥84 yr, Charlson comorbidity index ≥2 points, Braden score on admission to hospital≤16 points, preoperative urea nitrogen ≥8.8 mmol/L and postoperative albumin ≤ 29.6 g/L are the independent risk factors for 1-year mortality after hip fracture surgery in elderly patients, and the prediction model established based on the above indicators has good efficacy.
5.Advances in degradation mechanisms of 1,2,3-trichloropropane and remediation technology of contaminated sites.
Yaozhi ZHANG ; Huijuan JIN ; Xiuying LI ; Yufang SONG ; Jun YAN ; Yi YANG
Chinese Journal of Biotechnology 2021;37(10):3578-3590
1,2,3-trichloropropane (TCP) is an industrially synthesized aliphatic chlorinated hydrocarbon and an intermediate product in the industrial production of epichlorohydrin, which can be used as a precursor for the manufacture of soil fumigant and organic solvents. Due to its biological toxicity, environmental persistence and strong environmental migration ability, 1,2,3-TCP is listed as an emerging organochlorine pollutant in the environment and regulated by many international organizations. Currently, the degradation of 1,2,3-TCP and the remediation of 1,2,3-TCP-contaminated sites receive great attention, but the degradation mechanism of 1,2,3-TCP has not been summarized in depth. This article discussed the origin of 1,2,3-TCP, its environmental impact and ecological effects, and the physical and chemical degradation techniques. This was followed by summarizing the degradation mechanisms of 1,2,3-TCP (e.g., aerobic co-biodegradation, anaerobic biodegradation). Specially, the pathways and mechanisms of microbial biodegradation and transformation of 1,2,3-TCP in anoxic environments (e.g., groundwater) were thoroughly reviewed. The feasibility of using 1,2,3-TCP as an electron acceptor by organohalide-respiring bacteria under anoxic conditions was predicted based on thermodynamic analysis. Last but not least, in situ bioremediation of 1,2,3-TCP contaminated sites was summarized, and prospects for future research were discussed.
Biodegradation, Environmental
;
Environmental Restoration and Remediation
;
Hydrocarbons, Chlorinated
;
Propane/analogs & derivatives*
;
Technology